Comparative pharmacodynamic and pharmacokinetic study of MIDD0301 and its (S) enantiomer.
Comparative pharmacodynamic and pharmacokinetic study of MIDD0301 and its (S) enantiomer.
复制标题
DOI:
10.1002/ddr.21926
复制
发表时间:
2022-06
影响因子:
3.8
通讯作者:
Arnold, Leggy A.
中科院分区:
文献类型:
--
作者:
Roni, M. S. Rashid;Zahn, Nicolas M.;Yocum, Gene T.;Webb, Daniel A.;Mian, Md Yeunus;Meyer, Michelle J.;Tylek, Anika S.;Cook, James M.;Emala, Charles W.;Stafford, Douglas C.;Arnold, Leggy A.
MIDD0301 is being developed as an oral drug to relax airway smooth muscle and reduce lung inflammation in asthma. We report a comparative study of MIDD0301 and its S isomer (MIDD0301S) and found that the compounds have equivalent affinity for GABAAR expressed in rat brain, with IC50 values of 25.1 nM and 26.3 nM for the S and R enantiomers, respectively. Both compounds relaxed substance P contracted airway smooth muscle within 30 min and neither enantiomer revealed affinity to 48 receptors in an off-target screen. Both enantiomers reduced airway hyperresponsiveness (AHR) with nebulized and oral dosing in two mouse models of bronchoconstriction. In A/J mice, which are very sensitive to methacholine-induced bronchoconstriction, we observed reduction of AHR at 10.8 mg/kg MIDD0301 and 15 mg/kg MIDD0301S. Using oral administration, 100 mg/kg/day for three days of either enantiomer was sufficient to reduce AHR. In a model of severe airway inflammation induced by INFγ and LPS, we observed reduction of AHR at 7.2 mg/kg for both enantiomers using nebulized administration and at 100 mg/kg for oral administration. MIDD0301 and MIDD0301S did not undergo phase I metabolism. Glucuronidation was observed for both compounds, whereas only MIDD0301 formed the corresponding glucoside in the presence of kidney microsomes. Pharmacokinetic analysis identified glucuronides as the major metabolite with concentrations up to 20-fold more than the parent compound. MIDD0301 glucuronide and MIDD0301 taurine bind GABAARs, although 10-fold weaker than MIDD0301. In mouse blood, the taurine adduct was only observed for MIDD0301. Overall, both compounds exhibited similar receptor binding and pharmacodynamic properties with subtle differences in metabolism and greater oral availability and blood concentrations of MIDD0301S.
登录
查看更多内容
影响因子:
4.9
作者:
Forkuo GS;Guthrie ML;Yuan NY;Nieman AN;Kodali R;Jahan R;Stephen MR;Yocum GT;Treven M;Poe MM;Li G;Yu OB;Hartzler BD;Zahn NM;Ernst M;Emala CW;Stafford DC;Cook JM;Arnold LA
通讯作者:
Arnold LA
影响因子:
4.9
作者:
Forkuo GS;Nieman AN;Yuan NY;Kodali R;Yu OB;Zahn NM;Jahan R;Li G;Stephen MR;Guthrie ML;Poe MM;Hartzler BD;Harris TW;Yocum GT;Emala CW;Steeber DA;Stafford DC;Cook JM;Arnold LA
通讯作者:
Arnold LA
影响因子:
4.9
作者:
Forkuo GS;Nieman AN;Kodali R;Zahn NM;Li G;Rashid Roni MS;Stephen MR;Harris TW;Jahan R;Guthrie ML;Yu OB;Fisher JL;Yocum GT;Emala CW;Steeber DA;Stafford DC;Cook JM;Arnold LA
通讯作者:
Arnold LA
DOI:
10.1152/ajplung.00107.2014
发表时间:
2015-05-01
影响因子:
4.9
作者:
Gallos, George;Yocum, Gene T.;Emala, Charles W., Sr.
通讯作者:
Emala, Charles W., Sr.
影响因子:
7.3
作者:
IM, WB;PREGENZER, JF;THOMSEN, DR
通讯作者:
THOMSEN, DR